Literature DB >> 24430544

Combined zinc supplementation with proinsulin C-peptide treatment decreases the inflammatory response and mortality in murine polymicrobial sepsis.

Siarhei Slinko1, Giovanna Piraino, Paul W Hake, John R Ledford, Michael O'Connor, Patrick Lahni, Patrick D Solan, Hector R Wong, Basilia Zingarelli.   

Abstract

Zinc is a trace element vital for immune function during host response to infection. The proinsulin C-peptide has been shown to exert beneficial effects through activation of the anti-inflammatory peroxisome proliferator-activated receptor γ (PPARγ) in experimental endotoxemia. Some in vitro activities of C-peptide appear dependent on the presence of zinc. We investigated the effect of zinc supplementation before onset of sepsis on the anti-inflammatory properties of C-peptide. Male C57BL/6 mice were subjected to polymicrobial sepsis by cecal ligation and puncture (CLP). Mice received zinc gluconate (1.3 mg/kg) intraperitoneally (i.p.) for 3 days before CLP. One hour after CLP, animals received C-peptide (280 nmol/kg i.p.) or the antimicrobial agent imipenem (25 mg/kg i.p.). Cecal ligation and puncture was associated with an 11% survival rate, pulmonary leukosequestration, and liver injury. Molecular analysis in lungs of septic mice showed increased nuclear activation of the proinflammatory extracellular signal-regulated kinases 1 and 2 and nuclear factor κB, but decreased PPARγ expression, when compared with sham animals. Combination of zinc supplementation with C-peptide posttreatment significantly improved survival rate (61%) similarly to antibiotic treatment (60%), ameliorated lung architecture and liver function, reduced tissue neutrophil infiltration, and increased bacterial clearance when compared with vehicle, C-peptide, or zinc treatment alone. These beneficial effects were associated with restored lung nuclear expression of PPARγ and reduction of phosphorylated extracellular signal-regulated kinases 1 and 2 and nuclear factor κB activities in comparison to vehicle or single treatment protocols. Our data demonstrate that short-term zinc prophylaxis before the infectious insult is a requisite for the anti-inflammatory properties of C-peptide by facilitating modulation of inflammatory pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24430544      PMCID: PMC3968544          DOI: 10.1097/SHK.0000000000000127

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  35 in total

1.  C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia.

Authors:  Jaime Haidet; Vincenza Cifarelli; Massimo Trucco; Patrizia Luppi
Journal:  Inflamm Res       Date:  2011-09-27       Impact factor: 4.575

2.  Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent.

Authors:  Bin Bao; Ananda S Prasad; Frances W J Beck; James T Fitzgerald; Diane Snell; Ginny W Bao; Tapinder Singh; Lavoisier J Cardozo
Journal:  Am J Clin Nutr       Date:  2010-04-28       Impact factor: 7.045

3.  Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB.

Authors:  Shengying Bao; Ming-Jie Liu; Bryan Lee; Beth Besecker; Ju-Ping Lai; Denis C Guttridge; Daren L Knoell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-03-05       Impact factor: 5.464

4.  C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.

Authors:  L H Young; Y Ikeda; R Scalia; A M Lefer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

5.  Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2.

Authors:  Yoshiyuki Tanabe; Masaru Koga; Maki Saito; Yumi Matsunaga; Koichi Nakayama
Journal:  J Cell Sci       Date:  2004-07-15       Impact factor: 5.285

6.  Mass spectrometric characterization and activity of zinc-activated proinsulin C-peptide and C-peptide mutants.

Authors:  Zachary Keltner; Jennifer A Meyer; Erin M Johnson; Amanda M Palumbo; Dana M Spence; Gavin E Reid
Journal:  Analyst       Date:  2009-12-04       Impact factor: 4.616

7.  Zinc deficiency increases organ damage and mortality in a murine model of polymicrobial sepsis.

Authors:  Daren L Knoell; Mark W Julian; Shengying Bao; Beth Besecker; Jennifer E Macre; George D Leikauf; Robert A DiSilvestro; Elliott D Crouser
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

8.  Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice.

Authors:  Michael G Vish; Prajakta Mangeshkar; Giovanna Piraino; Alvin Denenberg; Paul W Hake; Michael O'Connor; Basilia Zingarelli
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

9.  A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream.

Authors:  Wathsala Medawala; Patrick McCahill; Adam Giebink; Jennifer Meyer; Chia-Jui Ku; Dana M Spence
Journal:  Rev Diabet Stud       Date:  2009-11-10

10.  Zinc competition among the intestinal microbiota.

Authors:  Lindsay M Gielda; Victor J DiRita
Journal:  MBio       Date:  2012-07-31       Impact factor: 7.867

View more
  6 in total

Review 1.  C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?

Authors:  C W Pinger; K E Entwistle; T M Bell; Y Liu; D M Spence
Journal:  Mol Biosyst       Date:  2017-07-25

2.  Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer.

Authors:  Michael J Story
Journal:  Biochimie       Date:  2021-05-31       Impact factor: 4.079

3.  Differential expression of the nuclear-encoded mitochondrial transcriptome in pediatric septic shock.

Authors:  Scott L Weiss; Natalie Z Cvijanovich; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Thomas P Shanley; Michael T Bigham; Julie Fitzgerald; Sharon Banschbach; Eileen Beckman; Kelli Howard; Erin Frank; Kelli Harmon; Hector R Wong
Journal:  Crit Care       Date:  2014-11-19       Impact factor: 9.097

4.  An In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to Erythrocytes.

Authors:  Sarah Y Lockwood; Suzanne Summers; Eric Eggenberger; Dana M Spence
Journal:  EBioMedicine       Date:  2016-08-04       Impact factor: 8.143

Review 5.  Trace Elements, PPARs, and Metabolic Syndrome.

Authors:  Yujie Shi; Yixin Zou; Ziyue Shen; Yonghong Xiong; Wenxiang Zhang; Chang Liu; Siyu Chen
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

Review 6.  C-Peptide as a Therapy for Type 1 Diabetes Mellitus.

Authors:  Rachel L Washburn; Karl Mueller; Gurvinder Kaur; Tanir Moreno; Naima Moustaid-Moussa; Latha Ramalingam; Jannette M Dufour
Journal:  Biomedicines       Date:  2021-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.